Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: An amygdaloid variant of Alzheimer disease

Archives of Neurology

Volumn 66, Issue 1, 2009, Pages 125-129

  Kile, Shawn J ^a   Ellis, William G ^a   Olichney, John M ^a   Farias, Sarah ^a   Decarli, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; KLUVER BUCY SYNDROME; MALE; MINI MENTAL STATE EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; AMYGDALA; AUTOPSY; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; KLUVER-BUCY SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBRILLARY TANGLES; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENILE PLAQUES;

EID: 58449131941     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2008.517     Document Type: Article

References (20)

1. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995;16(3):271-278.
2. Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience. 1990;37(2):377-385.
3. Hedreen JC, Broadhead JC, Price DL. Senile plaques in the amygdala in Alzheimer's disease. Neurology. 1988;38(2)(suppl 1):227.
4. Brady DR, Mufson EJ. Amygdaloid pathology in Alzheimer's disease: qualitative and quantitative analysis. Dementia. 1990;1:5-17.
5. Unger JW, Lapham LW, McNeill TH, Eskin TA, Hamill RW. The amygdala in Alzheimer's disease: neuropathology and Alz 50 immunoreactivity. Neurobiol Aging. 1991;12(5):389-399.
6. Kluver H, Bucy PC. Preliminary analysis of the temporal lobes in monkeys. Arch Neurol Psychiat. 1939;42:979-1000.
7. Mesulam MM. Behavioral neuroanatomy: large-scale networks, association cortex, frontal syndrome, the limbic system, and hemispheric specializations. In: Principles of Behavioral and Cognitive Neurology. 2nd ed. New York, NY: Oxford University Press; 2000:56-59.
8. King BM. Amygdaloid lesion-induced obesity: relation to sexual behavior, olfaction, and the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2006;291(5):R1201-R1214.
9. Freese JL, Amaral DG. The organization of projections from the amygdala to visual cortical areas TE and V1 in the macaque monkey. J Comp Neurol. 2005;486(4):295-317.
10. Sourander P, Sjogren H. The concept of Alzheimer's disease and its clinical implications. In: Wolstenholme GEW, O'Connor M, eds. Alzheimer's Disease and Related Conditions. London, England: Churchill Livingstone; 1970:11-36.
11. Morris CH, Hope RA, Fairburn CG. Eating habits in dementia: a descriptive study. Br J Psychiatry. 1989;154:801-806.
12. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease, IV: disorders of behaviour. Br J Psychiatry. 1990;157:86-94.
13. Scott SA, DeKosky ST, Sparks DL, Knox CA, Scheff SW. Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol. 1992;32(4):555-563.
14. Herzog AG, Kemper TL. Amygdaloid changes in aging and dementia. Arch Neurol. 1980;37(10):625-629.
15. Hayman LA, Rexer JL, Pavol MA, Strite D, Meyers CA. Klüver-Bucy syndrome after bilateral selective damage of amygdala and its cortical connections. J Neuropsychiatry Clin Neurosci. 1998;10(3):354-358.
16. Johnson JK, Head E, Kim R, Starr A, Cotman CW. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol. 1999;56(10):1233-1239.
17. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
18. Rascovsky K, Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65(3):397-403.
19. Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007;130(pt 10):2616-2635.
20. Jagust W, Reed B, Mungas D, Ellis W, DeCarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology. 2007;69(9):871-877.